Drug: ACTEMRA Injury: Peripheral swelling Quarter: 2016Q3
Total Records: 92 Number of Pages: 5
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
90304409 | ACTEMRA | Peripheral swelling | ROCHE | 42.75 YR | F | 68 KG | 20160808 | CA |
105290178 | ACTEMRA | Peripheral swelling | SYMPLMED PHARMACEUTICALS | 0.00 | 0 | 20160727 | CA | |
105503593 | ACTEMRA | Peripheral swelling | ROCHE | 0.00 | M | 70 KG | 20160927 | CH |
105920528 | ACTEMRA | Peripheral swelling | ROCHE | 53.82 YR | M | 90 KG | 20160726 | BR |
107539586 | ACTEMRA | Peripheral swelling | ROCHE | 44.10 YR | F | 0 | 20160920 | CA |
109828985 | ACTEMRA | Peripheral swelling | ROCHE | 80.67 YR | F | 47 KG | 20160914 | BR |
111951523 | ACTEMRA | Peripheral swelling | ROCHE | 63.20 YR | F | 0 | 20160829 | CA |
112531578 | ACTEMRA | Peripheral swelling | ABBVIE | 33.00 YR | F | 0 | 20160713 | CA |
112573037 | ACTEMRA | Peripheral swelling | ROCHE | 27.77 YR | F | 66 KG | 20160831 | CA |
113981193 | ACTEMRA | Peripheral swelling | AMGEN | 46.00 YR | F | 0 | 20160713 | CA |
114444528 | ACTEMRA | Peripheral swelling | ROCHE | 54.63 YR | F | 0 | 20160912 | CA |
114930513 | ACTEMRA | Peripheral swelling | AMGEN | 41.00 YR | M | 0 | 20160719 | CA |
115950735 | ACTEMRA | Peripheral swelling | AMGEN | 33.00 YR | F | 0 | 20160715 | CA |
116314048 | ACTEMRA | Peripheral swelling | ROCHE | 0.00 | F | 0 | 20160908 | CA |
117015188 | ACTEMRA | Peripheral swelling | PFIZER | 33.00 YR | F | 0 | 20160729 | CA |
117337985 | ACTEMRA | Peripheral swelling | AMGEN | 50.00 YR | F | 81 KG | 20160719 | CA |
117453813 | ACTEMRA | Peripheral swelling | AMGEN | 49.00 YR | F | 0 | 20160720 | CA |
117845764 | ACTEMRA | Peripheral swelling | ROCHE | 39.81 YR | F | 67 KG | 20160921 | BR |
118352578 | ACTEMRA | Peripheral swelling | ROCHE | 66.87 YR | M | 122 KG | 20160920 | CA |
118603844 | ACTEMRA | Peripheral swelling | AMGEN | 52.00 YR | F | 0 | 20160811 | CA |
Total Records: 92 Number of Pages: 5